查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1964085

脸颊填充市场－全球产业规模、份额、趋势、机会、预测：按产品、技术、最终用户、地区和竞争对手划分，2021-2031年

Cheek Augmentation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technique, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球脸颊容量增强市场预计将从 2025 年的 45.6 亿美元成长到 2031 年的 72.8 亿美元，复合年增长率为 8.11%。

脸颊填充术是指使用植入、注射填充剂或自体脂肪移植等美容手术，旨在恢復脸颊部位的容量并重塑其轮廓。推动市场成长的主要因素包括全球人口老化，人们希望解决与老龄化相关的容量流失问题，以及社会对美容手术的接受度不断提高。此外，非手术治疗方法的普及也使更多人能够获得此类服务，让患者能够在最短的恢復时间内获得更清晰的脸部轮廓。

市场概览
预测期 2027-2031
市场规模：2025年 45.6亿美元
市场规模：2031年 72.8亿美元
复合年增长率：2026-2031年 8.11%
成长最快的细分市场 非手术
最大的市场 北美洲

儘管存在这些市场驱动因素，但也存在一些障碍，例如永久性手术的高成本以及神经损伤和不对称等併发症风险，这些都可能阻碍潜在客户。然而，统计数据证实了市场对脸部容量填充的强劲需求，支撑着该领域的蓬勃发展。根据国际美容整形外科学会（ISAPS）的预测，到2024年，全球整体脸部脂肪移植手术的数量预计将增加19.2%，达到约90万例。这一显着成长凸显了消费者对脸部美学修復的持续关注，并展现了该市场的强劲表现。

市场驱动因素

微创和非手术脸部整形手术日益普及，是全球脸颊填充市场的主要驱动力。由于恢復时间更短、初始费用更低，且能够根据个人需求客製化效果并实现可逆性，患者越来越倾向于选择注射式皮肤填充剂而非传统的手术植入。玻尿酸类产品的多功能性进一步推动了这一趋势，这类产品无需全身麻醉即可立即改善面中部容量。美国整形外科医师协会在2025年6月发布的报告也印证了这一趋势，报告预测2024年透明质酸填充剂注射手术数量将达到5,331,426例，凸显了注射疗法在面部年轻化领域的优势。

同时，人口老化加剧和脸部容量流失的普遍存在显着推动了市场扩张，而近期快速减重药物的副作用也为其发展提供了助力。随着老龄化和体重减轻，脸颊部天然脂肪垫逐渐减少，人们对使用自体脂肪移植和生物刺激剂来恢復脸部容量的需求日益增长，以改善由此产生的凹陷。自体脂肪移植手术数量的增加清晰地反映了这一趋势，美国脸部整形与重组外科医师协会报告称，2024年脸部脂肪移植手术量平均增加50%。这项需求为行业收入做出了巨大贡献，高德美公司报告称，截至2025年9月的九个月内，其填充剂和生物刺激剂部门的净销售额为8.18亿美元。

市场挑战

全球脸颊填充市场的发展很大程度上受到永久性手术（尤其是外科手术）高昂费用和潜在併发症的限制。与暂时性填充剂不同，脸颊植入等永久性解决方案需要大量的预付费用，而且很少能获得保险报销。此外，这些手术的侵入性本身就存在感染疾病、神经损伤和脸部不对称等风险。这些经济和身体上的负担对许多潜在患者来说都是巨大的障碍，往往导致他们选择创伤较小的替代方案或彻底放弃治疗，从而阻碍了植入领域的成长。

这种犹豫也反映在脸颊整形手术的数量相对较少，与其他美容手术相比，这类手术的数量明显偏低。根据美国整形外科医师协会（ASPS）统计，2024年仅进行了9,130​​例脸颊植入手术。这一数字凸显了该手术的局限性，表明高昂的费用和相关的医疗风险有效地阻碍了可持续面部轮廓整形方案的普及，并限制了其整体市场潜力。

市场趋势

市场正经历着一场决定性的转变，从单纯的填充填充转向以结构修復为目标的生物刺激剂和再生注射剂。与传统的玻尿酸填充剂只能提供即时但短暂的丰盈效果不同，聚左旋乳酸和氢氧化钙羟基磷灰石等成分能够刺激人体自身胶原蛋白的生成，从而打造更持久、更自然的面颊轮廓。这种转变正受到寻求逐步改善肤质和结构完整性的患者的青睐。为了佐证这项需求，高德美公司在2025年3月公布，其2024年全年註射美容产品的净销售额达到22.99亿美元。这项业绩主要得益于其旗舰产品生物刺激剂Sculptra的两位数成长。

同时，针对男性脸部轮廓塑造和男性化治疗的拓展正在改变脸颊部填充领域的治疗通讯协定。男性患者越来越倾向于改善中脸部轮廓，以塑造更具棱角、更显力量感的颧骨结构，而非女性美感中常见的柔和饱满。这种人口结构的变化促使人们开发专门针对男性解剖结构的注射技术和植入设计。美国脸部整形与重组外科医师协会在2025年2月发布的报告也印证了这项变化，该报告显示，2024年有92%的脸部整形外科医师为男性患者提供治疗。在改善男性脸部特征方面，皮肤填充剂始终是首选的非手术方案。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球脸颊填充市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品类别（皮肤填充剂、植入、其他）
    • 依治疗方法（手术、非手术）
    • 按最终使用者（医院/诊所、门诊手术中心 (ASC)、专科诊所、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美脸颊填充市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲脸颊填充市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区脸颊填充市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲脸颊填充市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美脸颊填充市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球面颊填充市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Allergan, Inc.
  • Galderma SA
  • Mentor Worldwide LLC
  • Sientra, Inc.
  • Hugel, Inc.
  • Revance Therapeutics, Inc.
  • Croma-Pharma GmbH
  • HansBiomed Co., Ltd.
  • Teoxane SA
  • Establishment Labs Holdings Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 15567

The Global Cheek Augmentation Market is projected to grow from USD 4.56 Billion in 2025 to USD 7.28 Billion by 2031, reflecting an 8.11% CAGR. Cheek augmentation encompasses cosmetic interventions utilizing implants, injectable fillers, or fat transfers to restore volume and refine the contours of the zygomatic region. The primary drivers propelling this market include an aging global demographic seeking to correct age-related volume loss and the increasing social acceptance of aesthetic enhancements. Furthermore, the wide availability of non-surgical options has democratized access to these treatments, allowing patients to achieve facial definition with minimal recovery time.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.56 Billion
Market Size 2031USD 7.28 Billion
CAGR 2026-20318.11%
Fastest Growing SegmentNon-surgical
Largest MarketNorth America

Despite these drivers, the market faces obstacles such as the high cost of permanent procedures and the risk of complications like nerve damage or asymmetry, which may deter potential clients. However, statistical evidence confirms a robust demand for volumetric enhancement, supporting strong sector growth. According to the International Society of Aesthetic Plastic Surgery, facial fat grafting procedures rose by 19.2 percent globally in 2024, reaching approximately 900,000 cases. This significant increase underscores the enduring consumer interest in restorative facial aesthetics and validates the market's positive trajectory.

Market Driver

The surging adoption of minimally invasive and non-surgical facial procedures serves as a primary catalyst for the Global Cheek Augmentation Market. Patients increasingly prefer injectable dermal fillers over traditional surgical implants due to reduced recovery times, lower immediate costs, and the ability to achieve customizable, reversible results. This trend is further supported by the versatility of hyaluronic acid-based products, which offer immediate volumetric improvement to the mid-face without the risks of general anesthesia. Validating this preference, the American Society of Plastic Surgeons reported in June 2025 that hyaluronic acid filler treatments totaled 5,331,426 procedures in 2024, highlighting the dominance of injectable solutions in facial rejuvenation.

Simultaneously, the growing geriatric population and the prevalence of volume loss are significantly fueling market expansion, recently compounded by the side effects of rapid weight loss medications. As natural fat pads in the cheeks diminish due to aging or weight reduction, the demand for restorative volume using fat transfer or biostimulators increases to address the resulting hollowed appearance. This trend is evident in the rising use of autologous fat transfer; according to the American Academy of Facial Plastic and Reconstructive Surgery, the average number of facial fat grafting procedures increased by 50 percent in 2024. This demand translates into substantial industry revenue, with Galderma reporting net sales of 818 million USD for Fillers & Biostimulators in the first nine months of 2025.

Market Challenge

The expansion of the global cheek augmentation market is significantly impeded by the substantial expense of durable procedures and the potential for complications, particularly within the surgical segment. Unlike temporary injectables, permanent solutions such as cheek implants require a significant upfront financial investment that is rarely covered by insurance. Furthermore, the invasive nature of these surgeries carries inherent risks, including infection, nerve damage, and potential facial asymmetry. These financial and physical liabilities create high barriers for many prospective patients, often leading them to choose less invasive alternatives or forego treatment entirely, thereby stifling growth in the implant-based sector.

This hesitation is reflected in the comparatively low volume of surgical cheek enhancements versus other aesthetic procedures. According to the American Society of Plastic Surgeons, only 9,130 cheek implant procedures were performed in 2024. This figure highlights the restricted nature of the surgical segment, illustrating how high costs and associated medical risks effectively deter mass adoption and limit the overall market potential for durable facial contouring solutions.

Market Trends

The market is witnessing a decisive shift toward bio-stimulatory and regenerative injectables, moving beyond simple volume replacement to structural restoration. Unlike traditional hyaluronic acid fillers that provide immediate but temporary plumping, agents like poly-L-lactic acid and calcium hydroxylapatite stimulate the body's own collagen production for longer-lasting, natural-looking cheek contours. This transition appeals to patients seeking gradual improvements in skin quality and structural integrity. Substantiating this demand, Galderma reported in March 2025 that its Injectable Aesthetics net sales reached 2,299 million USD for the full year 2024, a performance significantly bolstered by double-digit growth in its flagship biostimulator, Sculptra.

Concurrently, the expansion of male-specific contouring and masculinization is reshaping treatment protocols within the cheek augmentation sector. Male patients are increasingly seeking mid-face enhancements to create angular, defined zygomatic structures that project strength, rather than the soft fullness associated with female aesthetics. This demographic surge has necessitated the development of specialized injection techniques and implant designs tailored to male anatomy. Highlighting this shift, the American Academy of Facial Plastic and Reconstructive Surgery reported in February 2025 that 92 percent of facial plastic surgeons treated male patients in 2024, with dermal fillers consistently ranking as a top non-surgical choice for enhancing male facial features.

Key Market Players

  • Allergan, Inc.
  • Galderma S.A.
  • Mentor Worldwide LLC
  • Sientra, Inc.
  • Hugel, Inc.
  • Revance Therapeutics, Inc.
  • Croma-Pharma GmbH
  • HansBiomed Co., Ltd.
  • Teoxane SA
  • Establishment Labs Holdings Inc.

Report Scope

In this report, the Global Cheek Augmentation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cheek Augmentation Market, By Product

  • Derma Fillers
  • Implant
  • Others

Cheek Augmentation Market, By Technique

  • Surgical
  • Non-surgical

Cheek Augmentation Market, By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Others

Cheek Augmentation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cheek Augmentation Market.

Available Customizations:

Global Cheek Augmentation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cheek Augmentation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Derma Fillers, Implant, Others)
    • 5.2.2. By Technique (Surgical, Non-surgical)
    • 5.2.3. By End User (Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Cheek Augmentation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technique
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cheek Augmentation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Cheek Augmentation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Cheek Augmentation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By End User

7. Europe Cheek Augmentation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technique
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cheek Augmentation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By End User
    • 7.3.2. France Cheek Augmentation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Cheek Augmentation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Cheek Augmentation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Cheek Augmentation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By End User

8. Asia Pacific Cheek Augmentation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technique
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cheek Augmentation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By End User
    • 8.3.2. India Cheek Augmentation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Cheek Augmentation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Cheek Augmentation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Cheek Augmentation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By End User

9. Middle East & Africa Cheek Augmentation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technique
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cheek Augmentation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Cheek Augmentation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Cheek Augmentation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By End User

10. South America Cheek Augmentation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technique
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cheek Augmentation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Cheek Augmentation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Cheek Augmentation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cheek Augmentation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Allergan, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Galderma S.A.
  • 15.3. Mentor Worldwide LLC
  • 15.4. Sientra, Inc.
  • 15.5. Hugel, Inc.
  • 15.6. Revance Therapeutics, Inc.
  • 15.7. Croma-Pharma GmbH
  • 15.8. HansBiomed Co., Ltd.
  • 15.9. Teoxane SA
  • 15.10. Establishment Labs Holdings Inc.

16. Strategic Recommendations

17. About Us & Disclaimer